We are committed to advancing radioisotope technology
NorthStar Medical Radioisotopes, LLC is a privately held nuclear medicine technology company committed to providing reliable and environmentally friendly radioisotope supply solutions to meet patient needs and advance clinical research. Founded in 2006 and based in Beloit, Wisconsin, NorthStar is a wholly-owned subsidiary of NorthStar Medical Technologies, LLC.
Partial funding for the RadioGenix® System (technetium Tc 99m generator) was provided by the U.S. Department of Energy’s (DOE) National Nuclear Security Administration (NNSA). NorthStar was the first company to be awarded a full $50 million Cooperative Agreement from the DOE and to date, NorthStar is the only company with two Cooperative Agreements in place with the DOE/NNSA. Each Cooperative Agreement is $50 million which means that the Company invests $25 million and the DOE matches the Company’s investment dollar for dollar.
In addition to NNSA funding, NorthStar partners with private investors through preferred stock financing.
Our valued partners include: